Previous close | 3.5000 |
Open | 3.0000 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 3.0000 - 3.5000 |
52-week range | 2.1200 - 18.0000 |
Volume | |
Avg. volume | 2,101 |
Market cap | 597.534M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Company’s flagship SSi Mantra surgical device has now been used in more than 1000 proceduresFORT LAUDERDALE, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the successful performance of the first pyeloplasty procedure performed on an infant utilizing its flagship
Significant milestones achieved for SSi Mantra Made-in-India surgical robotic system FORT LAUDERDALE, Fla., April 22, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced its Q1 2024 Company updates. As of March 31, 2024, SS Innovations has completed a total of 32 successfu
First-ever telesurgery using SSi Mantra performed on an animal in IndiaFORT LAUDERDALE, Fla., April 10, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced that its SSi Mantra Surgical Robotic System has successfully completed its first-ever telesurgery procedures on an an